Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer
2022 · The Prostate · 16 citations
https://doi.org/10.1002/pros.24400
P
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
128
Citations
6
h-index
5
i10-index
Pannaga Malalur is an academic researcher from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics. The author has an h-index of 6, co-authored 51 publications.
ORCID: 0000-0002-9222-4321Papers by this author
works389P Serum MUC5AC predicts recurrence in pancreatic ductal adenocarcinoma patients on neoadjuvant chemotherapy before resection
2024 · Annals of Oncology · 1 citations
https://doi.org/10.1016/j.annonc.2024.05.530
Cell-free DNA Methylation Signature-based Risk Prediction Model for Managing Pancreatic Ductal Adenocarcinoma Patients
2025 · The Journal of Liquid Biopsy · 0 citations
https://doi.org/10.1016/j.jlb.2025.100347
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat